Smith Group Asset Management’s ResMed RMD Stock Holding History

Smith Group Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$251K	Sell	1,290 -1,000	-44%	-$207K	0.01%	163
2026 Q1	$514K	Sell	2,290 -1,712	-43%	-$427K	0.03%	137
2025 Q4	$964K	Sell	4,002 -1,513	-27%	-$387K	0.05%	97
2025 Q3	$1.51M	Sell	5,515 -250	-4%	-$68.3K	0.09%	72
2025 Q2	$1.49M	Sell	5,765 -155	-3%	-$37K	0.1%	75
2025 Q1	$1.33M	Sell	5,920 -1,720	-23%	-$402K	0.1%	74
2024 Q4	$1.75M	Buy	7,640 +30	+0.4%	+$7.22K	0.13%	68
2024 Q3	$1.86M	Buy	7,610 +5,640	+286%	+$1.26M	0.15%	50
2024 Q2	$377K	Buy	+1,970	New	+$400K	0.03%	108
2014 Q1	–	Sell	-1,002,453	Closed	-$47.2M	–	423
2013 Q4	$47.2M	Sell	1,002,453 -15,784	-2%	-$799K	1.79%	9
2013 Q3	$53.8M	Sell	1,018,237 -35,580	-3%	-$1.73M	2.23%	4
2013 Q2	$47.5M	Buy	+1,053,817	New	+$50M	2.06%	5

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Smith Group Asset Management's RMD Position: Q2 2026 in Review

Smith Group Asset Management reduced its ResMed (RMD) stake by 44% in Q2 2026, selling an estimated $207K and leaving 1,290 shares worth $251K. The position accounts for 0.01% of the portfolio, ranked #163.

Smith Group Asset Management first reported a position in RMD in Q2 2013 and has held it in 12 quarters since. The position peaked at $53.8M in Q3 2013. 485 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Smith Group Asset Management held 1,290 shares of ResMed worth $251K as of Q2 2026.
Smith Group Asset Management sold 1,000 ResMed shares in Q2 2026, an estimated $207K.
ResMed made up 0.01% of Smith Group Asset Management's portfolio in Q2 2026, its #163 holding.
Smith Group Asset Management first reported a position in ResMed in Q2 2013 and has held it in 12 quarters since.
Smith Group Asset Management's ResMed position peaked at $53.8M in Q3 2013.
485 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Smith Group Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.